Perceived Barriers and Facilitators in Cardiovascular Risk Management in Colombia: A Qualitative Analysis of the RE-HOPE Study
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Type and Population
2.2. Sample Selection
2.3. Instruments and Data Collection Process
2.4. Processing and Analysis
3. Results
3.1. Findings by Category (Interpretative Analysis)
3.2. Findings from the Cluster Analysis
4. Discussion
5. Limitations
6. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Miranda, J.J.; Barrientos-Gutierrez, T.; Corvalan, C.; Hyder, A.A.; Lazo-Porras, M.; Oni, T.; Wells, J.C.K. Understanding the rise of cardiometabolic diseases in low- and middle-income countries. Nat. Med. 2019, 25, 1667–1679. [Google Scholar] [CrossRef] [PubMed]
- Joseph, P.; Lanas, F.; Roth, G.; Lopez-Jaramillo, P.; Lonn, E.; Miller, V.; Mente, A.; Leong, D.; Schwalm, J.D.; Yusuf, S. Cardiovascular disease in the Americas: The epidemiology of cardiovascular disease and its risk factors. Lancet Reg. Health Am. 2025, 42, 100960. [Google Scholar] [CrossRef] [PubMed]
- Wandell, P.E.; de Waard, A.M.; Holzmann, M.J.; Gornitzki, C.; Lionis, C.; de Wit, N.; Sondergaard, J.; Sonderlund, A.L.; Kral, N.; Seifert, B.; et al. Barriers and facilitators among health professionals in primary care to prevention of cardiometabolic diseases: A systematic review. Fam. Pract. 2018, 35, 383–398. [Google Scholar] [CrossRef] [PubMed]
- Souza, K.M.; Giron, N.; Vallini, J.; Hallar, K.; Ordunez, P.; Rosende, A.; Loya, B.R.; Sanchez, D.D.; Lim, C. Barriers to access to antihypertensive medicines: Insights from the HEARTS initiative in latin American and Caribbean region. J. Pharm. Policy Pract. 2024, 17, 2379045. [Google Scholar] [CrossRef] [PubMed]
- Lopez-Jaramillo, P.; Lopez-Lopez, J.P.; Otero, J.; Alarcon-Ariza, N.; Mogollon-Zehr, M.; Camacho, P.A.; Sanchez, G.; Narvaez, C.; Casanova, M.; Arcos, E.; et al. May Measurement Month 2019: An analysis of blood pressure screening results from Colombia. Eur. Heart J. Suppl. 2021, 23 (Suppl. B), B46–B48. [Google Scholar] [CrossRef] [PubMed]
- Khatib, R.; Schwalm, J.D.; Yusuf, S.; Haynes, R.B.; McKee, M.; Khan, M.; Nieuwlaat, R. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: A systematic review and meta-analysis of qualitative and quantitative studies. PLoS ONE 2014, 9, e84238. [Google Scholar] [CrossRef] [PubMed]
- Fade, S. Using interpretative phenomenological analysis for public health nutrition and dietetic research: A practical guide. Proc. Nutr. Soc. 2004, 63, 647–653. [Google Scholar] [CrossRef] [PubMed]
- Tong, A.; Sainsbury, P.; Craig, J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int. J. Qual. Health Care 2007, 19, 349–357. [Google Scholar] [CrossRef] [PubMed]
- Smith, J.; Firth, J. Qualitative data analysis: The framework approach. Nurse Res. 2011, 18, 52–62. [Google Scholar] [CrossRef] [PubMed]
- Lincoln, Y.S.; Guba, E.G. Naturalistic Inquiry; Sage: Beverly Hills, CA, USA, 1985. [Google Scholar]
- Legido-Quigley, H.; Camacho Lopez, P.A.; Balabanova, D.; Perel, P.; Lopez-Jaramillo, P.; Nieuwlaat, R.; Schwalm, J.D.; McCready, T.; Yusuf, S.; McKee, M. Patients’ knowledge, attitudes, behaviour and health care experiences on the prevention, detection, management and control of hypertension in Colombia: A qualitative study. PLoS ONE 2015, 10, e0122112. [Google Scholar] [CrossRef] [PubMed]
- Breneol, S.; Curran, J.A.; Marten, R.; Minocha, K.; Johnson, C.; Wong, H.; Langlois, E.V.; Wozney, L.; Velez, C.M.; Cassidy, C.; et al. Strategies to adapt and implement health system guidelines and recommendations: A scoping review. Health Res. Policy Syst. 2022, 20, 64. [Google Scholar] [CrossRef] [PubMed]
- Bishai, D.; Saleh, B.M.; Huda, M.; Aly, E.M.; Hafiz, M.; Ardalan, A.; Mataria, A. Practical strategies to achieve resilient health systems: Results from a scoping review. BMC Health Serv. Res. 2024, 24, 297. [Google Scholar] [CrossRef] [PubMed]
- Gibson, D.G.; Tamrat, T.; Mehl, G. The State of Digital Interventions for Demand Generation in Low- and Middle-Income Countries: Considerations, Emerging Approaches, and Research Gaps. Glob. Health Sci. Pract. 2018, 6 (Suppl. S1), S49–S60. [Google Scholar] [CrossRef] [PubMed]
- Avezum, A.; Perel, P.; Oliveira, G.B.F.; Lopez-Jaramillo, P.; Restrepo, G.; Loustalot, F.; Srur, A.; de La Noval, R.; Connell, K.I.; Cruz-Flores, S.; et al. Challenges and Opportunities to Scale Up Cardiovascular Disease Secondary Prevention in Latin America and the Caribbean. Glob. Heart 2018, 13, 83–91. [Google Scholar] [CrossRef] [PubMed]
- Schwalm, J.D.; McCready, T.; Lopez-Jaramillo, P.; Yusoff, K.; Attaran, A.; Lamelas, P.; Camacho, P.A.; Majid, F.; Bangdiwala, S.I.; Thabane, L.; et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): A cluster-randomised controlled trial. Lancet 2019, 394, 1231–1242. [Google Scholar] [CrossRef] [PubMed]
- Bovet, P.; Chiolero, A.; Paccaud, F.; Banatvala, N. Screening for cardiovascular disease risk and subsequent management in low and middle income countries: Challenges and opportunities. Public Health Rev. 2015, 36, 13. [Google Scholar] [CrossRef] [PubMed]
- Rasanathan, K.; Atkins, V.; Mwansambo, C.; Soucat, A.; Bennett, S. Governing multisectoral action for health in low-income and middle-income countries: An agenda for the way forward. BMJ Glob. Health 2018, 3 (Suppl. S4). [Google Scholar] [CrossRef] [PubMed]
- Bennett, S.; Glandon, D.; Rasanathan, K. Governing multisectoral action for health in low-income and middle-income countries: Unpacking the problem and rising to the challenge. BMJ Glob. Health 2018, 3 (Suppl. S4). [Google Scholar] [CrossRef] [PubMed]
Stakeholder | Questions |
---|---|
Territorial entities | -According to your experience, what are the reasons that guarantee the management of cardiovascular risk? -How is access to the cardiovascular risk management program regulated? -How can the cardiovascular risk management be improved in Santander? |
Healthcare insurers | -We would like to know in which way the activities between the entities and the community are articulated. -Describe how you manage the cardiovascular risk of your affiliates. |
Healthcare providers | -Describe the follow up done to the participants of the cardiovascular risk programs. -What do you think could be the actions or community strategies to recruit and monitor patients? -In your opinion, what actions can be implemented to improve the cardiovascular risk program in your institution? |
Stakeholder | Number of Focus Groups | Sex | Background | |
---|---|---|---|---|
Male | Female | |||
Territorial entities | 2 | 2 | 12 | Professional with specialty. |
Healthcare insurers | 2 | 2 | 3 | Specialized professionals. |
Healthcare providers | 1 | 0 | 6 | Doctors, nurses, and nursing assistants. |
Category | Proportion of Codes by Stakeholder | ||
---|---|---|---|
Healthcare Insurers (%) N = 5 | Territorial Entities (%) N = 14 | Healthcare Providers (%) N = 6 | |
Access (n = 14) | 0 | 21 | 79 |
Articulation (n = 17) | 71 | 18 | 11 |
Strategies (n = 26) | 54 | 27 | 19 |
Intersectorality (n = 6) | 0 | 50 | 50 |
Risk Measurement (n = 6) | 34 | 66 | 0 |
Stewardship (n = 3) | 0 | 100 | 0 |
Resources (n = 20) | 55 | 30 | 15 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lopez-Lopez, J.P.; Giraldo-Castrillon, Y.; Otero, J.; Torres, C.; Castañeda-Hernandez, A.; Martinez-Bello, D.; Garcia, C.; Lopez-Cabrera, M.; Lopez-Jaramillo, P. Perceived Barriers and Facilitators in Cardiovascular Risk Management in Colombia: A Qualitative Analysis of the RE-HOPE Study. Int. J. Environ. Res. Public Health 2025, 22, 1199. https://doi.org/10.3390/ijerph22081199
Lopez-Lopez JP, Giraldo-Castrillon Y, Otero J, Torres C, Castañeda-Hernandez A, Martinez-Bello D, Garcia C, Lopez-Cabrera M, Lopez-Jaramillo P. Perceived Barriers and Facilitators in Cardiovascular Risk Management in Colombia: A Qualitative Analysis of the RE-HOPE Study. International Journal of Environmental Research and Public Health. 2025; 22(8):1199. https://doi.org/10.3390/ijerph22081199
Chicago/Turabian StyleLopez-Lopez, Jose P., Yesica Giraldo-Castrillon, Johanna Otero, Claudia Torres, Alvaro Castañeda-Hernandez, Daniel Martinez-Bello, Claudia Garcia, Marianne Lopez-Cabrera, and Patricio Lopez-Jaramillo. 2025. "Perceived Barriers and Facilitators in Cardiovascular Risk Management in Colombia: A Qualitative Analysis of the RE-HOPE Study" International Journal of Environmental Research and Public Health 22, no. 8: 1199. https://doi.org/10.3390/ijerph22081199
APA StyleLopez-Lopez, J. P., Giraldo-Castrillon, Y., Otero, J., Torres, C., Castañeda-Hernandez, A., Martinez-Bello, D., Garcia, C., Lopez-Cabrera, M., & Lopez-Jaramillo, P. (2025). Perceived Barriers and Facilitators in Cardiovascular Risk Management in Colombia: A Qualitative Analysis of the RE-HOPE Study. International Journal of Environmental Research and Public Health, 22(8), 1199. https://doi.org/10.3390/ijerph22081199